|  ≥ 80 years old (n = 123) |  < 80 years old (n = 123) |  |
---|---|---|---|
Antiplatelet therapy | 82 (67%) | 110 (90%) | 0.0001 |
VKA | 15 (12%) | 10 (8%) | 0.0001 |
DOACs | 28 (23%) | 2 (2%) | 0.0001 |
Statin therapy | 79 (64%) | 95 (77%) | 0.035 |
ACE- inhibitor | 57 (46%) | 64 (52%) | 0.444 |
AT-II-receptor antagonist | 31 (25%) | 34 (28%) | 0.773 |
Beta-blockers | 73 (60%) | 80 (65%) | 0.430 |
Calcium channel blockers | 47 (38%) | 47 (38%) | 1 |
Aldosterone antagonists | 18 (15%) | 13 (11%) | 0.443 |
Thiazides | 35 (28%) | 30 (24%) | 0.563 |
Loop diuretics | 55 (45%) | 35 (28%) | 0.008 |